772 related articles for article (PubMed ID: 31034856)
1. A Prospective Randomized Trial Comparing Hydrus and iStent Microinvasive Glaucoma Surgery Implants for Standalone Treatment of Open-Angle Glaucoma: The COMPARE Study.
Ahmed IIK; Fea A; Au L; Ang RE; Harasymowycz P; Jampel HD; Samuelson TW; Chang DF; Rhee DJ;
Ophthalmology; 2020 Jan; 127(1):52-61. PubMed ID: 31034856
[TBL] [Abstract][Full Text] [Related]
2. A Randomized Trial of a Schlemm's Canal Microstent with Phacoemulsification for Reducing Intraocular Pressure in Open-Angle Glaucoma.
Pfeiffer N; Garcia-Feijoo J; Martinez-de-la-Casa JM; Larrosa JM; Fea A; Lemij H; Gandolfi S; Schwenn O; Lorenz K; Samuelson TW
Ophthalmology; 2015 Jul; 122(7):1283-93. PubMed ID: 25972254
[TBL] [Abstract][Full Text] [Related]
3. Ab interno trabecular bypass surgery with Schlemm´s canal microstent (Hydrus) for open angle glaucoma.
Otarola F; Virgili G; Shah A; Hu K; Bunce C; Gazzard G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012740. PubMed ID: 32147807
[TBL] [Abstract][Full Text] [Related]
4. Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma.
Saheb H; Donnenfeld ED; Solomon KD; Voskanyan L; Chang DF; Samuelson TW; Ahmed IIK; Katz LJ
Curr Eye Res; 2021 Feb; 46(2):224-231. PubMed ID: 32715828
[TBL] [Abstract][Full Text] [Related]
5. Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract: Two-Year Results.
Samuelson TW; Sarkisian SR; Lubeck DM; Stiles MC; Duh YJ; Romo EA; Giamporcaro JE; Hornbeak DM; Katz LJ;
Ophthalmology; 2019 Jun; 126(6):811-821. PubMed ID: 30880108
[TBL] [Abstract][Full Text] [Related]
6. Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study.
Hengerer FH; Auffarth GU; Riffel C; Conrad-Hengerer I
Adv Ther; 2019 Jul; 36(7):1606-1617. PubMed ID: 31119690
[TBL] [Abstract][Full Text] [Related]
7. Prospective Evaluation of Two iStent
Myers JS; Masood I; Hornbeak DM; Belda JI; Auffarth G; Jünemann A; Giamporcaro JE; Martinez-de-la-Casa JM; Ahmed IIK; Voskanyan L; Katz LJ
Adv Ther; 2018 Mar; 35(3):395-407. PubMed ID: 29476443
[TBL] [Abstract][Full Text] [Related]
8. A Schlemm Canal Microstent for Intraocular Pressure Reduction in Primary Open-Angle Glaucoma and Cataract: The HORIZON Study.
Samuelson TW; Chang DF; Marquis R; Flowers B; Lim KS; Ahmed IIK; Jampel HD; Aung T; Crandall AS; Singh K;
Ophthalmology; 2019 Jan; 126(1):29-37. PubMed ID: 29945799
[TBL] [Abstract][Full Text] [Related]
9. One-Year Comparative Evaluation of iStent or iStent inject Implantation Combined with Cataract Surgery in a Single Center.
Guedes RAP; Gravina DM; Lake JC; Guedes VMP; Chaoubah A
Adv Ther; 2019 Oct; 36(10):2797-2810. PubMed ID: 31440981
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive glaucoma surgery: Comparison of iStent with iStent inject in primary open angle glaucoma.
Hooshmand J; Rothschild P; Allen P; Kerr NM; Vote BJ; Toh T
Clin Exp Ophthalmol; 2019 Sep; 47(7):898-903. PubMed ID: 31034687
[TBL] [Abstract][Full Text] [Related]
11. Mid-term real world outcomes of the Hydrus
Kiramira D; Voßmerbäumer U; Pfeiffer N; Linnerth-Braun LKM; Lorenz K; Prokosch V
Eye (Lond); 2024 Jun; 38(8):1454-1461. PubMed ID: 38182656
[TBL] [Abstract][Full Text] [Related]
12. Three-Year Findings of the HORIZON Trial: A Schlemm Canal Microstent for Pressure Reduction in Primary Open-Angle Glaucoma and Cataract.
Ahmed IIK; Rhee DJ; Jones J; Singh IP; Radcliffe N; Gazzard G; Samuelson TW; Ong J; Singh K;
Ophthalmology; 2021 Jun; 128(6):857-865. PubMed ID: 33166551
[TBL] [Abstract][Full Text] [Related]
13. Hydrus microstent compared to selective laser trabeculoplasty in primary open angle glaucoma: one year results.
Fea AM; Ahmed II; Lavia C; Mittica P; Consolandi G; Motolese I; Pignata G; Motolese E; Rolle T; Frezzotti P
Clin Exp Ophthalmol; 2017 Mar; 45(2):120-127. PubMed ID: 27449488
[TBL] [Abstract][Full Text] [Related]
14. Microinvasive Glaucoma Stent (MIGS) Surgery With Concomitant Phakoemulsification Cataract Extraction: Outcomes and the Learning Curve.
Al-Mugheiry TS; Cate H; Clark A; Broadway DC
J Glaucoma; 2017 Jul; 26(7):646-651. PubMed ID: 28598959
[TBL] [Abstract][Full Text] [Related]
15. Trabecular micro-bypass stent implantation during small-incision cataract surgery for open-angle glaucoma or ocular hypertension: Long-term results.
Neuhann TH
J Cataract Refract Surg; 2015 Dec; 41(12):2664-71. PubMed ID: 26796447
[TBL] [Abstract][Full Text] [Related]
16. Outcomes Following Implantation of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication: 18-Month Follow-Up.
Lindstrom R; Lewis R; Hornbeak DM; Voskanyan L; Giamporcaro JE; Hovanesian J; Sarkisian S
Adv Ther; 2016 Nov; 33(11):2082-2090. PubMed ID: 27739003
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Safety and Efficacy of Hydrus and iStent Combined with Phacoemulsyfication in Open Angle Glaucoma Patients: 24-Month Follow-Up.
Jabłońska J; Lewczuk K; Rękas MT
Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901162
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Hydrus and iStent microinvasive glaucoma surgery implants in combination with phacoemulsification for treatment of open-angle glaucoma: systematic review and network meta-analysis.
Hu R; Guo D; Hong N; Xuan X; Wang X
BMJ Open; 2022 Jun; 12(6):e051496. PubMed ID: 35705355
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of phacoemulsification combined with two iStent inject trabecular microbypass stents with or without endocyclophotocoagulation.
Pantalon AD; Barata ADO; Georgopoulos M; Ratnarajan G
Br J Ophthalmol; 2020 Oct; 104(10):1378-1383. PubMed ID: 31980421
[TBL] [Abstract][Full Text] [Related]
20. Five-Year, Prospective, Randomized, Multi-Surgeon Trial of Two Trabecular Bypass Stents versus Prostaglandin for Newly Diagnosed Open-Angle Glaucoma.
Fechtner RD; Voskanyan L; Vold SD; Tetz M; Auffarth G; Masood I; Au L; Khouri AS; Ahmed IIK; Saheb H
Ophthalmol Glaucoma; 2019; 2(3):156-166. PubMed ID: 32672584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
